Comparing Benlysta vs Mycophenolate Mofetil
| Benlysta | Mycophenolate mofetil |
|
|---|
| Benlysta (belimumab) | Mycophenolate mofetil |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Benlysta is an injectable prescription medicine used with other medicines to treat systemic lupus erythematosus (SLE) and active lupus nephritis (lupus-related kidney inflammation) in adults and... View more |
Prescription only
Prescribed for Nephrotic Syndrome, Autoimmune Hepatitis, Lupus, Cogan's Syndrome, Bullous Pemphigoid, Crohn's Disease, Organ Transplant - Rejection Prophylaxis, Dermatomyositis, Evan's Syndrome... View more |
Related suggestions Lupus Nephritis
Popular comparisons
|
|||||||||||||||
| More about Benlysta (belimumab) | More about Mycophenolate mofetil | ||||||||||||||||
| Generic Status | |||||||||||||||||
|
No lower-cost generic available |
|||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Benlysta has an average rating of 7.8 out of 10 from a total of 54 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 8% reported a negative effect. |
Mycophenolate mofetil has an average rating of 7.9 out of 10 from a total of 60 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 11% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
See also: Benlysta side effects in more detail. |
See also: mycophenolate mofetil side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Benlysta prices |
View all mycophenolate mofetil prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
CellCept | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
465.6 hours |
18 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 148 drugs are known to interact with Benlysta:
|
A total of 327 drugs are known to interact with mycophenolate mofetil:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
March 09, 2011 |
May 03, 1995 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
|
|||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.